A study, performed by the Medical University of Vienna, examined diagnostic accuracy of SARS-CoV-2 rapid antigen tests compared to RT-PCR as the gold standard based on different swab sites by using Scarletred®Vision.

The popular newspaper Der Standard features the recent milestones of SCARLETRED in the field of teledermatology. With these, SCARLETRED sets the benchmark for AI-Assisted Screening in telemedicine and radiation oncology.

In an interview, specialist Dr. Zikeli discusses the clinical characteristics of atopic dermatitis and why documentation using Scarletred®Vision is an optimal support for diagnosis and progress monitoring.

Scarletred’s new digital market research solution offers biopharmaceutical and cosmetic companies high-quality, standardized data via Scarletred®Vision, enabling research from home with an easy-to-use kit and mobile app.

Hidradenitis suppurativa (HS) is an autoinflammatory skin condition that causes abscesses and scarring on the skin and affects about 1-4% of the total population (Ballard & Schuman, 2020). 

People suffering from atopic dermatitis struggle with the condition itself and stigmatization, making digital analysis of disease and treatment vital to clinical management to enhance their quality of life using SCARLETRED.

SCARLETRED’s certified medical device provides medical professionals with a novel digital solution to allow them to assess and analyze the individuals’ affected areas in an accurate, time-efficient, and user-friendly manner.

The traditional assessment of skin texture based on multiple health professionals can lead to inconsistent results making standardized digital dermatological monitoring, as provided by SCARLETRED, an essential tool.

Psoriasis is a chronic inflammatory disease of the skin associated with red, raised plaques and scaly skin. Psoriasis is a global problem affecting approximately 2-3% of the total population.

Patient-reported outcome (PRO) refers to a health outcome directly based on patient self-reporting. While some measures can be captured during site visits, others may be tracked more efficiently close to real-time.

SCARLETRED’s mobile technology, Scarletred®Vision, provides clinically validated R&D tools to document, analyse, and monitor skin color and pigmentation variations in multi-centric or home based cosmetics studies.

Onychomycosis is an infection of the nail caused by fungal organisms. With SCARLETRED’s digital technology, experts can quantify and monitor disease progression allowing for consistent and personalized treatment.

Being a chronic inflammatory skin disorder, patients with rosacea need standardized tools, as provided by SCARLETRED, to improve the condition’s analysis and treatment and overcome psychosocial stigmatization.

Standardized documentation and scoring of injection site reactions is a crucial part of clinical trials, as local development of skin erythema can reflect on the effectiveness and side effects of an investigational product.

Skin cancer is one of the most common types of cancer but also the most preventable one. The incidence rates for non-melanoma skin cancer drastically increased, and currently, there are 2-3 million cases each year.

Solar lentigo, also called age spots, is a common form of hyperpigmentation, especially in adults older than 50, caused by natural or artificial ultraviolet light exposure.

Vitiligo is a long-term pigmentation disorder affecting 0.5 - 1% of individual. SCARLETRED is revolutionizing dermatology by allowing the standardization of the assessment and monitoring of vitiligo.

The skin is the primary interface between nurse and patient. With SCARLETRED, pigmentation disorders can be objectively monitored, improving dermatological and cosmetic dermatological services.

Chronic wound is a medical condition, affecting up to 4% of all people worldwide. The wound care market is one of the biggest in the healthcare system globally, standing now at approx. USD 10.4 billion.

Non-healing wounds pose a significant challenge in clinical medicine and present severe difficulties to millions of patients worldwide. The management of chronic wounds remains a challenging task in terms of their assessment.

Due to the COVID-19 pandemic, researchers need to adjust clinical trial setups due to the stay-at-home orders and risk of virus transmission. The golden time of virtual and home-based clinical trials has started.